Updates are available Erratum dated 2016-04-19
Click to view Erratum: https://doi.org/10.1038/mp.2016.57
-
Authors
Suo, C
Singh, M F
Gates, N
Wen, W
Sachdev, P https://orcid.org/0000-0002-9595-3220
Brodaty, H
Saigal, N
Wilson, G C
Meiklejohn, J
Singh, N
Baune, B T
Baker, M
Foroughi, N
Wang, Y
Mavros, Y https://orcid.org/0000-0002-2588-0425
Lampit, A
Leung, I
Valenzuela, M J
- License Information
-
More Information
Article History
Received: 13 July 2015
Revised: 12 January 2016
Accepted: 20 January 2016
First Online: 22 March 2016
Competing interests
: The authors declare no conflict of interest. MJV has previously received honoraria for speaking at Pfizer and The Brain Department LLC-sponsored events, has received research funding from The Brain Department LLC for unrelated work and currently receives in-kind research support in the form of no-cost software from BrainTrain Inc (USA) and in-kind research support from NeuroNation for unrelated projects. HB has been an investigator for Pfizer, Novartis, Janssen, Lilly, Medivation, Sanofi and Servier; a sponsored speaker for Pfizer, Novartis, Janssen and Lundbeck; and is on advisory Boards for Pfizer, Novartis, Janssen, Lundbeck, Merck and Baxter. BTB is a member of advisory boards and/or gave presentations for the following companies, for which he received honoraria: AstraZeneca, Lundbeck, Pfizer, Servier and Wyeth. NG holds shares in HeadStrong Brain LLC New York although no dividends, gifts or royalties have ever been received and no work has been conducted for the company since 2007.
